We look forward to meeting you at ASGCT!

Ncardia’s mission is to bring better therapies to patients faster through iPSC technologies.

We are proud to present our new brand Cellistic, to help therapeutic developers advance their cell therapy innovations. Our expertise in iPSC technology and human biology enables us to deliver the differentiation and scale-up required for successful allogeneic cell therapy development.

Ncardia provides a comprehensive menu of tailored drug discovery services for any therapeutic modality, including gene therapy - from disease modeling to drug efficacy and safety assessments.

Brands: Ncardia, Cellistic